ACM
JNJ icon

Armbruster Capital Management’s Johnson & Johnson JNJ Stock Holding History

Armbruster Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
1,613
+156
+11% +$36.4K 0.06% 98
2026
Q1 		$356K Buy
1,457
+295
+25% +$68.7K 0.06% 112
2025
Q4 		$240K Hold
1,162
– – 0.04% 126
2025
Q3 		$215K Buy
+1,162
New +$199K 0.04% 128
2024
Q4 		– Sell
-1,260
Closed -$204K – 134
2024
Q3 		$204K Sell
1,260
-570
-31% -$90.8K 0.04% 129
2024
Q2 		$267K Sell
1,830
-75
-4% -$11.2K 0.06% 106
2024
Q1 		$301K Hold
1,905
– – 0.06% 91
2023
Q4 		$299K Sell
1,905
-1
-0.1% -$153 0.07% 88
2023
Q3 		$297K Sell
1,906
-650
-25% -$107K 0.08% 87
2023
Q2 		$423K Buy
2,556
+108
+4% +$17.4K 0.1% 78
2023
Q1 		$379K Sell
2,448
-550
-18% -$88.8K 0.1% 82
2022
Q4 		$530K Sell
2,998
-50
-2% -$8.63K 0.14% 61
2022
Q3 		$498K Sell
3,048
-475
-13% -$80.4K 0.14% 62
2022
Q2 		$625K Sell
3,523
-10
-0.3% -$1.78K 0.17% 59
2022
Q1 		$626K Buy
3,533
+125
+4% +$21.3K 0.15% 62
2021
Q4 		$583K Buy
3,408
+143
+4% +$23.4K 0.13% 71
2021
Q3 		$527K Hold
3,265
– – 0.15% 55
2021
Q2 		$538K Hold
3,265
– – 0.15% 54
2021
Q1 		$537K Hold
3,265
– – 0.16% 47
2020
Q4 		$514K Sell
3,265
-20
-0.6% -$2.95K 0.17% 46
2020
Q3 		$489K Buy
3,285
+3
+0.1% +$444 0.19% 46
2020
Q2 		$462K Buy
3,282
+17
+0.5% +$2.48K 0.19% 45
2020
Q1 		$428K Sell
3,265
-325
-9% -$46.1K 0.2% 48
2019
Q4 		$524K Hold
3,590
– – 0.2% 40
2019
Q3 		$464K Sell
3,590
-133
-4% -$17.5K 0.19% 43
2019
Q2 		$519K Sell
3,723
-191
-5% -$26.4K 0.22% 40
2019
Q1 		$547K Sell
3,914
-95
-2% -$12.7K 0.24% 40
2018
Q4 		$517K Sell
4,009
-227
-5% -$31.7K 0.26% 38
2018
Q3 		$585K Buy
4,236
+551
+15% +$73.2K 0.26% 39
2018
Q2 		$447K Sell
3,685
-64
-2% -$7.99K 0.21% 44
2018
Q1 		$480K Sell
3,749
-578
-13% -$78.1K 0.22% 43
2017
Q4 		$605K Sell
4,327
-20
-0.5% -$2.79K 0.28% 35
2017
Q3 		$565K Hold
4,347
– – 0.29% 34
2017
Q2 		$575K Buy
4,347
+518
+14% +$66.1K 0.31% 35
2017
Q1 		$477K Sell
3,829
-196
-5% -$23.4K 0.27% 35
2016
Q4 		$464K Sell
4,025
-200
-5% -$23.1K 0.27% 34
2016
Q3 		$499K Sell
4,225
-213
-5% -$25.8K 0.31% 33
2016
Q2 		$538K Buy
4,438
+30
+0.7% +$3.41K 0.35% 31
2016
Q1 		$477K Buy
4,408
+120
+3% +$12.4K 0.33% 34
2015
Q4 		$440K Buy
+4,288
New +$431K 0.39% 35

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Armbruster Capital Management's JNJ Position: Q2 2026 in Review

Armbruster Capital Management increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $36.4K and bringing the position to 1,613 shares worth $410K. The position accounts for 0.06% of the portfolio, ranked #98.

Armbruster Capital Management first reported a position in JNJ in Q4 2015 and has held it in 40 quarters since. The position peaked at $626K in Q1 2022. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Armbruster Capital Management held 1,613 shares of Johnson & Johnson worth $410K as of Q2 2026.
  • Armbruster Capital Management bought 156 Johnson & Johnson shares in Q2 2026, an estimated $36.4K.
  • Johnson & Johnson made up 0.06% of Armbruster Capital Management's portfolio in Q2 2026, its #98 holding.
  • Armbruster Capital Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 40 quarters since.
  • Armbruster Capital Management's Johnson & Johnson position peaked at $626K in Q1 2022.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.